Selective and rapid uptake of adeno-associated virus type 2 in brain - PubMed (original) (raw)
Selective and rapid uptake of adeno-associated virus type 2 in brain
J S Bartlett et al. Hum Gene Ther. 1998.
Abstract
Recombinant adeno-associated virus (AAV) vectors effectively transfer and express foreign genes in the brain. The transferred genes, however, are selectively expressed in neurons, and the cause of this specificity is not understood. To address this question, wild-type AAV-2 capsids were covalently labeled with the fluorophore, Cy3, and infused into the inferior colliculus or the hippocampus. Using antibodies to identify neurons (NeuN), astrocytes (GFAP), or oligodendrocytes (OX-42), clear neuron-specific uptake of the virus was observed as early as 6 min after the start of the infusion. By 30 min postinfusion, AAV particles were present in the nucleus of neurons, yet in both the inferior colliculus and hippocampus, a subset of neurons did not take up the virus particles. No AAV particles were found in astrocytes 1.5 min or 24 hr after virus infusion. Interestingly, 1 hr postinfusion, no AAV particles were found in microglia, yet by 24 hr postinfusion, a punctate pattern of AAV particles was found in microglia. To test whether virus uptake correlated with vector-transduced cells, an rAAV-CMV-GFP virus was infused. By 3 days postinfusion, GFP was localized to neuronal populations with no expression in astrocytes or microglia, similar to that of fluorescent virus uptake. These findings demonstrate that in brain, AAV particles rapidly bind and enter primarily neurons with a pattern similar to that of in vivo vector transduction. In addition, these studies indicate that viral binding and uptake, independent of promoter tropism, can explain the specificity of AAV brain transduction. Thus, this first description of AAV kinetic disposition in vivo should facilitate targeted application of this vector for human brain gene therapy.
Similar articles
- Specific gene expression in mouse cortical astrocytes is mediated by a 1740bp-GFAP promoter-driven combined adeno-associated virus 2/5/7/8/9.
Meng X, Yang F, Ouyang T, Liu B, Wu C, Jiang W. Meng X, et al. Neurosci Lett. 2015 Apr 23;593:45-50. doi: 10.1016/j.neulet.2015.03.022. Epub 2015 Mar 13. Neurosci Lett. 2015. PMID: 25778419 - Basic fibroblast growth factor enhances transduction, distribution, and axonal transport of adeno-associated virus type 2 vector in rat brain.
Hadaczek P, Mirek H, Bringas J, Cunningham J, Bankiewicz K. Hadaczek P, et al. Hum Gene Ther. 2004 May;15(5):469-79. doi: 10.1089/10430340460745793. Hum Gene Ther. 2004. PMID: 15144577 - Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus.
Ehrengruber MU, Hennou S, Büeler H, Naim HY, Déglon N, Lundstrom K. Ehrengruber MU, et al. Mol Cell Neurosci. 2001 May;17(5):855-71. doi: 10.1006/mcne.2001.0982. Mol Cell Neurosci. 2001. PMID: 11358483 - Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
Shevtsova Z, Malik JM, Michel U, Bähr M, Kügler S. Shevtsova Z, et al. Exp Physiol. 2005 Jan;90(1):53-9. doi: 10.1113/expphysiol.2004.028159. Epub 2004 Nov 12. Exp Physiol. 2005. PMID: 15542619 Review. - Recombinant adeno-associated virus vectors for gene therapy.
Conlon TJ, Flotte TR. Conlon TJ, et al. Expert Opin Biol Ther. 2004 Jul;4(7):1093-101. doi: 10.1517/14712598.4.7.1093. Expert Opin Biol Ther. 2004. PMID: 15268676 Review.
Cited by
- In Vivo Targeting of the Neurovascular Unit: Challenges and Advancements.
Naranjo O, Osborne O, Torices S, Toborek M. Naranjo O, et al. Cell Mol Neurobiol. 2022 Oct;42(7):2131-2146. doi: 10.1007/s10571-021-01113-3. Epub 2021 Jun 4. Cell Mol Neurobiol. 2022. PMID: 34086179 Free PMC article. Review. - Ciliary neurotrophic factor receptor regulation of adult forebrain neurogenesis.
Lee N, Batt MK, Cronier BA, Jackson MC, Bruno Garza JL, Trinh DS, Mason CO, Spearry RP, Bhattacharya S, Robitz R, Nakafuku M, MacLennan AJ. Lee N, et al. J Neurosci. 2013 Jan 16;33(3):1241-58. doi: 10.1523/JNEUROSCI.3386-12.2013. J Neurosci. 2013. PMID: 23325260 Free PMC article. - Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis.
Passini MA, Dodge JC, Bu J, Yang W, Zhao Q, Sondhi D, Hackett NR, Kaminsky SM, Mao Q, Shihabuddin LS, Cheng SH, Sleat DE, Stewart GR, Davidson BL, Lobel P, Crystal RG. Passini MA, et al. J Neurosci. 2006 Feb 1;26(5):1334-42. doi: 10.1523/JNEUROSCI.2676-05.2006. J Neurosci. 2006. PMID: 16452657 Free PMC article. - Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state.
Fischer D, He Z, Benowitz LI. Fischer D, et al. J Neurosci. 2004 Feb 18;24(7):1646-51. doi: 10.1523/JNEUROSCI.5119-03.2004. J Neurosci. 2004. PMID: 14973241 Free PMC article. - Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.
Kwon I, Schaffer DV. Kwon I, et al. Pharm Res. 2008 Mar;25(3):489-99. doi: 10.1007/s11095-007-9431-0. Epub 2007 Sep 1. Pharm Res. 2008. PMID: 17763830 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous